Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors — Stella

Home/Ovarian Germ Cell Cancer/TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors

View on ClinicalTrials.gov

Recruiting

Back to Ovarian Germ Cell Cancer trials

TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Qilu Hospital of Shandong University, Jinan, Shandong

Key details

Phase

Large-scale testing

Sponsor

Beihua Kong

Collaborators

Huazhong University of Science and Technology, Zhejiang University

Enrollment target

~129 participants

Started

April 2015

Primary completion

May 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

14 Years – 65 Years

Sex

Female only

Last updated April 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.